Nose to brain targeting of the donepezil nanostructured lipid carrier in situ gel: formulation, in vitro , ex vivo , in vivo pharmacokinetic and pharmacodynamic characterization
RSC Pharmaceutics · 2024 · 1 (4) · 820-840
DOI: 10.1039/d4pm00174e ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2024. Verfasst von Devika Sonawane und 1 weiteren Autor:innen. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: All India Council for Technical Education.
Abstract (Originalsprache)
Exploring nose to brain potential of DPZ in situ gel.
Förderung
- All India Council for Technical Education
Zitieren
APA
Sonawane, D., & Pokharkar, V. (2024). Nose to brain targeting of the donepezil nanostructured lipid carrier in situ gel: formulation, in vitro , ex vivo , in vivo pharmacokinetic and pharmacodynamic characterization. RSC Pharmaceutics, 1(4), 820-840. https://doi.org/10.1039/d4pm00174e
Vancouver
Sonawane D, Pokharkar V. Nose to brain targeting of the donepezil nanostructured lipid carrier in situ gel: formulation, in vitro , ex vivo , in vivo pharmacokinetic and pharmacodynamic characterization. RSC Pharmaceutics. 2024;1(4):820-840. doi:10.1039/d4pm00174e
BibTeX
@article{Sonawane2024,
author = {Sonawane, Devika and Pokharkar, Varsha},
title = {Nose to brain targeting of the donepezil nanostructured lipid carrier in situ gel: formulation, in vitro , ex vivo , in vivo pharmacokinetic and pharmacodynamic characterization},
journal = {RSC Pharmaceutics},
year = {2024},
volume = {1},
number = {4},
pages = {820--840},
doi = {10.1039/d4pm00174e}
}
EUVIMED